Home Cart Sign in  
Chemical Structure| 103-16-2 Chemical Structure| 103-16-2

Structure of Monobenzone
CAS No.: 103-16-2

Chemical Structure| 103-16-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Monobenzone is a compound used as a topical agent for medical depigmentation.

Synonyms: Benoquin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Monobenzone

CAS No. :103-16-2
Formula : C13H12O2
M.W : 200.23
SMILES Code : C2=C(OCC1=CC=CC=C1)C=CC(=C2)O
Synonyms :
Benoquin
MDL No. :MFCD00002333
InChI Key :VYQNWZOUAUKGHI-UHFFFAOYSA-N
Pubchem ID :7638

Safety of Monobenzone

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H316-H317-H319
Precautionary Statements:P261-P264-P272-P280-P302+P352-P305+P351+P338-P333+P313-P337+P313-P362+P364-P501

Isoform Comparison

Biological Activity

Target
  • tyrosinase

In Vitro:

Cell Line
Concentration Treated Time Description References
NB4 cells 18.04 ± 3.36 μM 72 hours MB inhibited NB4 cell proliferation with an IC50 of 18.04 ± 3.36 μM. Cancers (Basel). 2022 Sep 27;14(19):4710
MOLM13 cells 6.07 ± 1.55 μM 72 hours MB inhibited MOLM13 cell proliferation with an IC50 of 6.07 ± 1.55 μM. Cancers (Basel). 2022 Sep 27;14(19):4710
KG-1A cells 13.9 ± 1.64 μM 72 hours MB inhibited KG-1A cell proliferation with an IC50 of 13.9 ± 1.64 μM. Cancers (Basel). 2022 Sep 27;14(19):4710
Human primary melanocytes 5 μM 72 hours To evaluate the effect of Monobenzone on melanin content. The results showed that Monobenzone significantly decreased melanin content in human primary melanocytes. J Pharm Anal. 2024 Jan;14(1):69-85
MNT-1 cells 5 μM 72 hours To evaluate the effect of Monobenzone on melanin content. The results showed that Monobenzone significantly decreased melanin content in MNT-1 melanoma cells. J Pharm Anal. 2024 Jan;14(1):69-85
B16F10 cells 5 μM 72 hours To evaluate the effect of Monobenzone on melanin content. The results showed that Monobenzone significantly decreased melanin content in B16F10 melanoma cells. J Pharm Anal. 2024 Jan;14(1):69-85

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Monobenzone-induced depigmentation model Topical application 40% (m/m) Once daily for 54 days To evaluate the effect of Monobenzone on dorsal hair color in mice. The results showed that Monobenzone significantly reduced pigmentation in the dorsal hair of mice. J Pharm Anal. 2024 Jan;14(1):69-85
Mice Monobenzone-induced vitiligo model Topical application 40% monobenzone solution, 50 mg per day Once daily for 45 days To evaluate the therapeutic effects of taVNS in a mouse model of vitiligo, results showed that taVNS significantly alleviated symptoms, particularly by reducing the depigmented areas Int J Mol Sci. 2024 Mar 18;25(6):3411
C57BL/6 mice MBEH-induced vitiligo model Topical application 40% (50 mg per day) Once daily for two weeks, repeated for three rounds MBEH significantly induced depigmentation in mice and increased the infiltration of CD8+ T cells in the skin. Int J Mol Sci. 2023 Apr 10;24(8):6990
Nude mice AML xenograft model Intraperitoneal injection 150 or 200 mg/kg Once daily for two weeks MB significantly inhibited the growth of AML xenografts in nude mice with relatively low toxicity. Cancers (Basel). 2022 Sep 27;14(19):4710

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.99mL

1.00mL

0.50mL

24.97mL

4.99mL

2.50mL

49.94mL

9.99mL

4.99mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories